{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:42:05Z","timestamp":1761972125617,"version":"build-2065373602"},"reference-count":41,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.2169\/internalmedicine.5192-24","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:07:47Z","timestamp":1744999667000},"page":"3088-3102","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Importance of Optimal Medical Therapy on the Clinical Outcomes of Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention"],"prefix":"10.2169","volume":"64","author":[{"given":"Hirokazu","family":"Shimono","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kagoshima City Hospital, Japan"},{"name":"Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tokushige","sequence":"additional","affiliation":[{"name":"Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan"},{"name":"Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Arikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kagoshima City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Okui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kagoshima City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Oketani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kagoshima City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan"},{"name":"Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Krumholz HM, Wang Y, Chen J, et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA 302: 767-773, 2009.","DOI":"10.1001\/jama.2009.1178"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 156: 1026-1034, 2008.","DOI":"10.1016\/j.ahj.2008.07.030"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Daida H, Miyauchi K, Ogawa H, et al.; the PACIFIC investigators. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 77: 934-943, 2013.","DOI":"10.1253\/circj.CJ-13-0174"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gochi T, Matsumoto K, Amin R, Kitazawa T, Seto K, Hasegawa T. Cost of illness of ischemic heart disease in Japan: a time trend and future projections. Environ Health Prev Med 23: 21, 2018.","DOI":"10.1186\/s12199-018-0708-1"},{"key":"5","unstructured":"5. Ministry of Health, Labour and Welfare, Japan. Population dynamic statistics. Number of deaths and rate of deaths by sex and cause of death simple classification [Internet]. [cited 2024 Apr 21]. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei22\/dl\/11_h7.pdf (in Japanese)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kimura K, Kimura T, Ishihara M, et al.; the Japanese Circulation Society Joint Working Group. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J 83: 1085-1196, 2019.","DOI":"10.1253\/circj.CJ-19-0133"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 130: 2354-2394, 2014.","DOI":"10.1161\/CIR.0000000000000133"},{"key":"8","first-page":"e362","volume":"127","author":"PT O'Gara","year":"2013","unstructured":"8. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 127: e362-e425, 2013.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"9","unstructured":"9. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44: 3720-3826, 2023."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wongsalap Y, Kengkla K, Poolpun D, Saokaew S. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. J Cardiol 77: 669-676, 2021.","DOI":"10.1016\/j.jjcc.2020.12.015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yan AT, Yan RT, Tan M, et al.; the Canadian ACS Registries Investigators. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J 154: 1108-1115, 2007.","DOI":"10.1016\/j.ahj.2007.07.040"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tomasevic D, El Khoury C, Subtil F, et al. Effect of optimal medical therapy at discharge in patients with reperfused ST-segment elevation myocardial infarction on 1-year Mortality (from the Regional RESCUe Registry). Am J Cardiol 121: 403-409, 2018.","DOI":"10.1016\/j.amjcard.2017.11.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lee K, Han S, Lee M, et al. Evidence-based optimal medical therapy and mortality in patients with acute myocardial infarction after percutaneous coronary intervention. J Am Heart Assoc 12: e024370, 2023.","DOI":"10.1161\/JAHA.121.024370"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. He X, Wang Y, Cong H, Lu C, Wu J. Impact of optimal medical therapy at discharge on one-year direct medical costs in patients with acute coronary syndromes: a retrospective, observational database analysis in China. Clin Ther 41: 456-465.e2, 2019.","DOI":"10.1016\/j.clinthera.2019.01.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Byeon HJ, Yang YM, Choi EJ. Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea. Ther Clin Risk Manag 12: 167-175, 2016.","DOI":"10.2147\/TCRM.S99869"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 136: 341-348, 2002.","DOI":"10.7326\/0003-4819-136-5-200203050-00005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 82: 1311-1317, 1998.","DOI":"10.1016\/S0002-9149(98)00633-X"},{"key":"18","unstructured":"18. Alexander KP, Roe MT, Chen AY, et al.; the CRUSADE Investigators. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46: 1479-1487, 2005."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Paul SD, O'Gara PT, Mahjoub ZA, et al. Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 131: 710-715, 1996.","DOI":"10.1016\/S0002-8703(96)90275-6"},{"key":"20","unstructured":"20. Skolnick AH, Alexander KP, Chen AY, et al. Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol 49: 1790-1797, 2007."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bauer T, Koeth O, J\u00fcnger C, et al.; the Acute Coronary Syndromes Registry (ACOS) Investigators. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J 28: 2873-2878, 2007.","DOI":"10.1093\/eurheartj\/ehm464"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ouchi Y, Rakugi H, Arai H, et al.; the Joint Committee of Japan Gerontological Society (JGLS) and Japan Geriatrics Society (JGS) on the definition and classification of the elderly. Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int 17: 1045-1047, 2017.","DOI":"10.1111\/ggi.13118"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nakamura M, Kimura K, Kimura T, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 84: 831-865, 2020.","DOI":"10.1253\/circj.CJ-19-1109"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsukawa R, Okahara A, Tokutome M, et al. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients. ESC Heart Fail 10: 3352-3363, 2023.","DOI":"10.1002\/ehf2.14524"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Matsukawa R, Kabu K, Koga E, et al. Optimizing guideline-directed medical therapy during hospitalization improves prognosis in patients with worsening heart failure requiring readmissions. Circ J 88: 1416-1424, 2024.","DOI":"10.1253\/circj.CJ-24-0265"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45: 1397-1405, 2005.","DOI":"10.1016\/j.jacc.2005.01.041"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Haider A, Bengs S, Luu J, et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J 41: 1328-1336, 2020.","DOI":"10.1093\/eurheartj\/ehz898"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Akahori H, Masuyama T, Imanaka T, et al.; J-MINUET investigators. Impact of peripheral artery disease on prognosis after myocardial infarction: the J-MINUET study. J Cardiol 76: 402-406, 2020.","DOI":"10.1016\/j.jjcc.2020.05.014"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mori H, Fukui K, Maeda A, et al. Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry. J Cardiol 79: 768-775, 2022.","DOI":"10.1016\/j.jjcc.2022.02.007"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Prosser HC, Peck KY, Dinh D, et al. Role of renin-angiotensin system antagonists on long-term mortality post-percutaneous coronary intervention in reduced and preserved ejection fraction. Clin Res Cardiol 111: 776-786, 2022.","DOI":"10.1007\/s00392-021-01985-x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kim KH, Choi BG, Rha SW, Choi CU, Jeong MH; Other KAMIR-NIH investigators. Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR). BMC Cardiovasc Disord 21: 251, 2021.","DOI":"10.1186\/s12872-021-02070-x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yang JH, Hahn JY, Song YB, et al. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv 7: 592-601, 2014.","DOI":"10.1016\/j.jcin.2013.12.206"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kim J, Kang D, Park H, et al. Long-term \u03b2-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study. Eur Heart J 41: 3521-3529, 2020.","DOI":"10.1093\/eurheartj\/ehaa376"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Schwartz GG, Olsson AG, Ezekowitz MD, et al.; the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285: 1711-1718, 2001.","DOI":"10.1001\/jama.285.13.1711"},{"key":"36","unstructured":"36. Ray KK, Cannon CP, McCabe CH, et al.; the PROVE IT-TIMI 22 Investigators. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46: 1405-1410, 2005."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Rosano GMC, Moura B, Metra M, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23: 872-881, 2021.","DOI":"10.1002\/ejhf.2206"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ueshima K, Fukami K, Hiramori K, et al.; Japanese Angina and Myocardial Infarction Prospective (JAMP) study group. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study. Am Heart J 148: e8, 2004.","DOI":"10.1016\/j.ahj.2004.03.035"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Watanabe H, Ozasa N, Morimoto T, et al.; the CAPITAL-RCT investigators. Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. PLoS ONE 13: e0199347, 2018.","DOI":"10.1371\/journal.pone.0199347"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ishihara M, Nakao K, Ozaki Y, et al.; J-MINUET Investigators. Long-term outcomes of non-ST-elevation myocardial infarction without creatine kinase elevation - the J-MINUET study. Circ J 81: 958-965, 2017.","DOI":"10.1253\/circj.CJ-17-0033"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Kohro T, Hayashi D, Yamazaki T, Nagai R; the JCAD Investigators. Beta-blocker prescription among Japanese cardiologists and its effect on various outcomes. Circ J 74: 962-969, 2010.","DOI":"10.1253\/circj.CJ-09-0613"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/21\/64_5192-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:26:37Z","timestamp":1761967597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/21\/64_5192-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":41,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5192-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"5192-24"}}